Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.569 USD | +7.18% | +6.32% | -72.91% |
Apr. 08 | Eyenovia to Weigh Potential Sale, Other Strategic Alternatives | MT |
Apr. 08 | Eyenovia Explores Wide Range of Strategic Alternatives | CI |
Financials (USD)
Sales 2024 * | 5.23M | Sales 2025 * | 11.93M | Capitalization | 27.05M |
---|---|---|---|---|---|
Net income 2024 * | -32M | Net income 2025 * | -42M | EV / Sales 2024 * | 5.17 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.27 x |
P/E ratio 2024 * |
-0.77
x | P/E ratio 2025 * |
-0.59
x | Employees | 57 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.8% |
Latest transcript on Eyenovia, Inc.
1 day | -1.56% | ||
1 week | -10.32% | ||
Current month | -46.16% | ||
1 month | -65.30% | ||
3 months | -66.61% | ||
6 months | -60.53% | ||
Current year | -74.48% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 50 | 14-03-11 | |
Michael Rowe
CEO | Chief Executive Officer | 62 | 18-07-08 |
John Gandolfo
DFI | Director of Finance/CFO | 63 | 17-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | Nov. 13 | |
Ellen Strahlman
BRD | Director/Board Member | 66 | - |
Michael Rowe
CEO | Chief Executive Officer | 62 | 18-07-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +1.04% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 0.561 | +5.67% | 328 218 |
24-04-18 | 0.5309 | -1.56% | 575,667 |
24-04-17 | 0.5393 | -2.55% | 741,111 |
24-04-16 | 0.5534 | +0.67% | 885,822 |
24-04-15 | 0.5497 | +3.72% | 1,699,361 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-74.48% | 27.05M | |
+27.97% | 672B | |
+23.58% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.96% | 211B | |
-0.41% | 203B | |
-10.02% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- EYEN Stock